|
HCG18 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
2.86604073806984E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
4.257200E-01 |
| Stage1-vs-Stage3 |
2.500000E-02 |
| Stage1-vs-Stage4 |
1.694160E-01 |
| Stage2-vs-Stage3 |
2.351500E-02 |
| Stage2-vs-Stage4 |
7.138000E-02 |
| Stage3-vs-Stage4 |
7.383000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.72030000245016E-08 |
| Normal-vs-Asian |
1.66300306858602E-12 |
| Caucasian-vs-AfricanAmerican |
3.689600E-01 |
| Caucasian-vs-Asian |
1.831810E-01 |
| AfricanAmerican-vs-Asian |
9.602400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
4.423000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
3.69890000000428E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.959970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.839600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.132400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.456800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.701000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.592600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.51149999999745E-06 |
| Classical-VS-Follicular |
8.863200E-01 |
| Classical-VS-Other |
1.075610E-01 |
| Classical-VS-Normal |
2.99760216648792E-15 |
| Tall-VS-Follicular |
2.832200E-04 |
| Tall-VS-Other |
6.570000E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.174200E-01 |
| Follicular-VS-Normal |
1.62925228863742E-12 |
| Other-VS-Normal |
1.30870000003558E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.37587727269783E-14 |
| N0-vs-N1 |
9.721200E-01 |
|
|
